COSCIENS Biopharma Overview

COSCIENS Biopharma Other Income Expense Net

Other Income/Expense Net for AEZS.

Quarterly Other Income/Expense

$1.88M

↑ 6866.67% YoY

As of Jun 30, 2024

Annual Other Income/Expense (TTM)

$3.01M

↑ 136.82% YoY

Trailing 12 months ending Jun 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin